Drugs / DWC202011
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04772443 Comparator | Feb 2021 → Dec 2022 | hyperlipidemia | Daewoong Pharmaceutical Co. LTD. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DWC202011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04772443 ↗ |